Table 5.
Health utilities evaluation of the African American versus European American patient cohort.
| Health utilities | Overall, mean (SD) | African American, mean (SD) | European American, mean (SD) | P valuea | |
| Visual analog scale, mean (SD) |
|
||||
|
|
Hemodialysis | 57.9 (25.9) | 59.1 (27.4) | 55.1 (22.4) | .38 |
|
|
Kidney transplant | 88.2 (17.8) | 86.7 (20.3) | 91.8 (9.3) | .73 |
|
|
Hepatitis C–viremic kidney transplantb | 66.30 (27.3) | 65.6 (27.4) | 68.0 (27.8) | .70 |
| Standard gamble, mean (SD) |
|
||||
|
|
Hemodialysis | 82.5 (23.1) | 83.0 (25.2) | 81.3 (17.6) | .22 |
|
|
Kidney transplant | 89.0 (18.0) | 88.8 (19.6) | 89.4 (14.3) | .52 |
|
|
Hepatitis C–viremic kidney transplantb | 75.5 (28.2) | 77.5 (28.5) | 70.9 (27.5) | .24 |
| Time trade-off |
|
||||
|
|
Hemodialysis, mean (IQR; SD) | 80.3 (66.0-100.0; 20.5) | 83.2 (75.0-100.0; 21.0) | 73.6 (66.0-83.5; 18.2) | .04 |
|
|
Kidney transplant, mean (SD) | 84.8 (22.0) | 85.2 (23.8) | 84.0 (17.7 | .16 |
|
|
Hepatitis C–viremic kidney transplantb, mean (SD) | 73.8 (28.1) | 75.4 (29.7) | 70.0 (21.0) | .20 |
aP value denotes comparison between race-matched and race-mismatch population health utilities. This assumes that if P≤.05, there was a significant difference in health utilities between race-matched (same race) and race-mismatched (different race) health utilities.
bHealth utility normalization equation: Raw hepatitis C virus utility * Kidney transplant utility = hepatitis C virus utility.